Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution
- Recalling company
- Wells Pharma of Houston LLC
- Product
- fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02.
- Reason
- cGMP deviations.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Apr 1, 2026
- Reported
- May 6, 2026
- Distribution
- U.S. Nationwide.
- Status
- Ongoing
- Quantity
- 4,030 IV Bags
- Lot / codes
- 120925202022769, Expiration Date 04/09/2026, 123125202022883, Expiration Date 05/05/2026, 123125202022884, Expiration Date 05/05/2026 011226202020057, Expiration Date 05/14/2026, 011226202020058, Expiration Date 05/14/2026, 011626202020110, Expiration Date 05/20/2026 012726202020156, Expiration Date 05/28/2026. 012726202020161, Expiration Date 05/28/2026 020226202020195, Expiration Date 06/04/2026 021826202020386, Expiration Date 06/20/2026 022026202020417, Expiration Date 06/24/2026 022026202020424 Expiration Date 06/24/2026
- Company location
- Houston, TX
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0503-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0503-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.